Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
1.75%1.81%22.51x1.89x3.11x11.05x18.14x 6.71TCr
2.81%2.91%53.11x6.04x4.94x20.09x27.91x 29TCr
2.87%3.06%15.56x1.35x1.94x6.68x8.04x 784.46Cr
-.--%-.--%22.12x6.16x6.62x18.11x18.9x 454.14Cr
0.72%0.73%42.86x2.55x2.43x29.57x43.81x 379.78Cr
-.--%-.--%102.49x - - - - 257.75Cr
-.--%-.--%-7.91x13.22x219.92x-7.08x-5.54x 103.26Cr
4.1%3.95%12.48x0.83x1.12x28.06x-76.45x 101.05Cr
Average 1.53% 1.56% 32.90x 4.58x 34.30x 15.21x 4.97x 4.77TCr
Weighted average by Cap. 2.55% 2.64% 46.56x 5.18x 5.13x 18.23x 25.46x
Specialty & Advanced Pharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!